Results 1 to 10 of about 6,905 (159)

Structural basis for childhood antibody recognition of the human metapneumovirus fusion protein [PDF]

open access: yesNature Communications
Human metapneumovirus (hMPV) is a significant cause of acute respiratory illness in children and older adults, with most children becoming seropositive by five years of age.
Ahmed Magdy Khalil   +7 more
doaj   +2 more sources

Intranasal bovine/human parainfluenza virus 3 vaccine candidates expressing human metapneumovirus wild-type or pre-fusion F protein elicit protective immunity against human metapneumovirus in hamsters [PDF]

open access: yesJournal of Virology
Human metapneumovirus (HMPV) and human parainfluenza virus 3 (HPIV3) are among the leading causes of severe pediatric respiratory illness worldwide, and there are no licensed vaccines.
Sirle Saul   +9 more
doaj   +2 more sources

Emergence and epidemiology of dominant variants of human metapneumovirus in the United States between 2016 and 2021 [PDF]

open access: yesmBio
Human metapneumovirus (HMPV) causes acute respiratory disease worldwide and is the second leading cause of lower respiratory infection and hospitalization in young children in the USA. There is no licensed vaccine or therapeutic.
Lora Lee Pless   +15 more
doaj   +2 more sources

Human metapneumovirus: pathogenesis, epidemiology, diagnostic technologies, and potential intervention strategies [PDF]

open access: yesVirology Journal
Human metapneumovirus (HMPV) is a notable viral pathogen that is responsible for respiratory tract infections in infants, young children, elderly individuals, and immunocompromised individuals.
Guicai Gao, Ruihong Lin, Dongli Ma
doaj   +2 more sources

A chimeric influenza virus vaccine expressing fusion protein epitopes induces protection from human metapneumovirus challenge in mice

open access: yesFrontiers in Microbiology, 2023
Human metapneumovirus (HMPV) is a common virus associated with acute respiratory distress syndrome in pediatric patients. There are no HMPV vaccines or therapeutics that have been approved for prevention or treatment.
Tian Chongyu   +13 more
doaj   +1 more source

HMPV in Immunocompromised Patients: Frequency and Severity in Pediatric Oncology Patients

open access: yesPathogens, 2020
Cancer is the first cause of death by disease in childhood globally. The most frequent types of cancers in children and adolescents are leukemias, followed by brain and central nervous system tumors and lymphomas.
Cesar Martinez-Rodriguez   +1 more
doaj   +1 more source

The human metapneumovirus matrix protein stimulates the inflammatory immune response in vitro. [PDF]

open access: yesPLoS ONE, 2011
Each year, during winter months, human Metapneumovirus (hMPV) is associated with epidemics of bronchiolitis resulting in the hospitalization of many infants.
Audrey Bagnaud-Baule   +8 more
doaj   +1 more source

Human Metapneumovirus Is Capable of Entering Cells by Fusion with Endosomal Membranes. [PDF]

open access: yesPLoS Pathogens, 2015
Human metapneumovirus (HMPV), a member of the Paramyxoviridae family, is a leading cause of lower respiratory illness. Although receptor binding is thought to initiate fusion at the plasma membrane for paramyxoviruses, the entry mechanism for HMPV is ...
Reagan G Cox   +6 more
doaj   +1 more source

Epidemiology, genetic characteristics, and association with meteorological factors of human metapneumovirus infection in children in southern China: A 10-year retrospective study

open access: yesInternational Journal of Infectious Diseases, 2023
Objectives: This study aimed to determine the epidemiological and genetic features of human metapneumovirus (HMPV) infection in children in southern China, and the effect of meteorological factors on infection.
Hengming Ye   +13 more
doaj   +1 more source

Human metapneumovirus (hMPV): a re-emerging respiratory threat – transmission, clinical features, complications and management [PDF]

open access: yesInfectious Diseases and Tropical Medicine
Human metapneumovirus (hMPV) is a globally prevalent yet underrecognized respiratory pathogen that disproportionately affects high-risk populations. Between 2024 and January 2025, numerous hMPV clinical cases were recorded in China, India, and other ...
S. Aishath   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy